419 related articles for article (PubMed ID: 27289488)
1. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Bleker SM; Buchmüller A; Chauleur C; Ní Áinle F; Donnelly J; Verhamme P; Jacobsen AF; Ganzevoort W; Prins M; Beyer-Westendorf J; DeSancho M; Konstantinides S; Pabinger I; Rodger M; Decousus H; Middeldorp S
Thromb Res; 2016 Aug; 144():62-8. PubMed ID: 27289488
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
3. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM; Buchmüller A; Wiegers HMG; Ní Áinle F; Tardy B; Donnelly J; Verhamme P; Jacobsen AF; Hansen AT; Rodger MA; DeSancho MT; Shmakov RG; van Es N; Prins MH; Chauleur C; Middeldorp S; ;
Lancet; 2022 Nov; 400(10365):1777-1787. PubMed ID: 36354038
[TBL] [Abstract][Full Text] [Related]
4. [Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
Ned Tijdschr Geneeskd; 2011; 155():A3433. PubMed ID: 21527059
[TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
6. New studies of low-molecular-weight heparin in pregnancy.
Middeldorp S
Thromb Res; 2015 Feb; 135 Suppl 1():S26-9. PubMed ID: 25903529
[TBL] [Abstract][Full Text] [Related]
7. Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.
Bates SM; Alonso-Coello P; Tikkinen KA; Ebrahim S; Lopes LC; McDonald SD; Zhou Q; Akl EA; Neumann I; Jacobsen AF; Zhang Y; Santamaría A; Annichino-Bizzacchi JM; Sandset PM; Bitar W; Eckman MH; Guyatt GH
Thromb Res; 2016 Apr; 140():22-9. PubMed ID: 27500301
[TBL] [Abstract][Full Text] [Related]
8. Association between prophylactic low-molecular-weight heparin use in pregnancy and macrosomia: analysis of the Ottawa and Kingston birth cohort.
Lowry DE; Corsi DJ; White RR; Guo M; Lanes A; Smith G; Rodger M; Wen SW; Walker M; Gaudet L
J Thromb Haemost; 2019 Feb; 17(2):345-349. PubMed ID: 30552749
[TBL] [Abstract][Full Text] [Related]
9. Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study.
Dargaud Y; Rugeri L; Fleury C; Battie C; Gaucherand P; Huissoud C; Rudigoz RC; Desmurs-Clavel H; Ninet J; Trzeciak MC
J Thromb Haemost; 2017 May; 15(5):897-906. PubMed ID: 28231636
[TBL] [Abstract][Full Text] [Related]
10. Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.
Alonso-Coello P; Ebrahim S; Guyatt GH; Tikkinen KA; Eckman MH; Neumann I; McDonald SD; Akl EA; Bates SM
BMC Pregnancy Childbirth; 2012 May; 12():40. PubMed ID: 22646475
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?
Roeters van Lennep JE; Meijer E; Klumper FJ; Middeldorp JM; Bloemenkamp KW; Middeldorp S
J Thromb Haemost; 2011 Mar; 9(3):473-80. PubMed ID: 21232006
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
Bauersachs RM; Dudenhausen J; Faridi A; Fischer T; Fung S; Geisen U; Harenberg J; Herchenhan E; Keller F; Kemkes-Matthes B; Schinzel H; Spannagl M; Thaler CJ;
Thromb Haemost; 2007 Dec; 98(6):1237-45. PubMed ID: 18064320
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism.
Lindqvist PG; Bremme K; Hellgren M;
Acta Obstet Gynecol Scand; 2011 Jun; 90(6):648-53. PubMed ID: 21314819
[TBL] [Abstract][Full Text] [Related]
14. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
Labrador J; González-Rivero J; Monroy R; Lozano FS; López-Corral L; Caballero MD; Bastida JM; González-Porras JR
Thromb Res; 2016 Jun; 142():52-6. PubMed ID: 26922092
[TBL] [Abstract][Full Text] [Related]
15. The prevention of pregnancy-related venous thromboembolism.
Guimicheva B; Czuprynska J; Arya R
Br J Haematol; 2015 Jan; 168(2):163-74. PubMed ID: 25312482
[TBL] [Abstract][Full Text] [Related]
16. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
Jørgensen M; Broholm R; Bækgaard N
Phlebology; 2013 Mar; 28 Suppl 1():34-8. PubMed ID: 23482532
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
Cox S; Eslick R; McLintock C
J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
[TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism prophylaxis of the obese postpartum patient: A cross-sectional study.
Gilmartin CE; Cutts BA; Ismail H
Aust N Z J Obstet Gynaecol; 2020 Jun; 60(3):376-381. PubMed ID: 31514236
[TBL] [Abstract][Full Text] [Related]
20. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.
Skeith L; Carrier M; Robinson SE; Alimam S; Rodger MA
Blood; 2017 Feb; 129(8):934-939. PubMed ID: 28049641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
